Windlas Biotech consolidated net profit rises 150.68% in the March 2022 quarter

Sales rise 14.34% to Rs 122.13 crore

Net profit of Windlas Biotech rose 150.68% to Rs 14.79 crore in the quarter ended March 2022 as against Rs 5.90 crore during the previous quarter ended March 2021. Sales rose 14.34% to Rs 122.13 crore in the quarter ended March 2022 as against Rs 106.81 crore during the previous quarter ended March 2021.

For the full year,net profit rose 140.62% to Rs 38.09 crore in the year ended March 2022 as against Rs 15.83 crore during the previous year ended March 2021. Sales rose 8.96% to Rs 465.93 crore in the year ended March 2022 as against Rs 427.60 crore during the previous year ended March 2021.

 

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales122.13106.81 14 465.93427.60 9 OPM %11.3310.41 -11.2512.75 - PBDT16.5611.58 43 57.7156.33 2 PBT13.668.23 66 45.5743.36 5 NP14.795.90 151 38.0915.83 141

Powered by Capital Market - Live News